Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
PTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading PTX News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-0.05%10.709.9%$285.32m
PRGOPerrigo Co. Plc
-0.54%68.084.8%$178.27m
SHPGShire PLC Sponsored ADR
-0.40%173.460.3%$166.97m
MDCOMedicines Company
0.00%49.6522.6%$131.89m
ENDPEndo International Plc
0.00%9.878.9%$127.82m
UTHRUnited Therapeutics Corporation
0.00%139.3711.5%$96.60m
JAZZJazz Pharmaceuticals Plc
0.00%142.341.9%$84.80m
MNKMallinckrodt Plc
0.00%42.5312.8%$83.62m
PRXLPAREXEL International Corporation
0.00%62.006.7%$70.08m
PCRXPacira Pharmaceuticals, Inc.
0.00%48.1516.9%$65.90m
ICPTIntercept Pharmaceuticals, Inc.
0.00%116.2522.8%$53.53m
PTLAPortola Pharmaceuticals, Inc.
0.00%38.5110.3%$49.23m
HZNPHorizon Pharma plc
0.00%14.529.7%$46.12m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.00%119.509.9%$41.50m
ICLRICON Plc
0.00%78.082.8%$37.91m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.